Our CliCr^® technology platform: ready to connect

Suitable for generating superior and novel conjugate products including bioconjugate-based therapeutics, nanomedicines, biomaterials and diagnostics, our proprietary click chemistry platform is available for testing through joint proof of concept studies with further development under a license.

CliCr^® is also offered in partnership with Lonza as part of the Lonza Bioconjugation Toolbox and its Early Development Service (EDS) offering. Lonza can support the entire product lifecycle: from drug discovery and lead identification right through to commercial manufacturing.